The Latin
American pharmaceutical contract manufacturing services market is
anticipated to reach USD 21.0 billion by 2025, according to a new report by
Grand View Research, Inc. Low drug registration cost in Latin American
countries and continuous economic growth are the key factors contributing to
progress in this region. Moreover, Latin America offers higher recruitment
rates and relatively high competitive prices in comparison to United States and
other European countries.
A
forementioned fact pronounces the trend of shifting Contract
Manufacturing/Research Organizations (CMO/CRO)’s attention to Latin American
countries such as Brazil, Mexico, Argentina, and Colombia. Ongoing adjustment
in Latin America to reduce the commodity prices and domestic political
turbulence in each country is expected to shape region’s economic growth there
by driving revenue generation in the outsourcing market for pharmaceutical development.
To request a
sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/latin-america-pharmaceutical-contract-manufacturing-services-market
http://www.grandviewresearch.com/industry-analysis/latin-america-pharmaceutical-contract-manufacturing-services-market
Further key findings from the study suggest:
- Contract manufacturing services accounted for the largest share owing to wide range of services offered by the CMO’s located herein for therapeutic drug development
- API/Bulk drug development services accounted for the largest share over the other segments as companies continue to invest for API production capacity enhancement
- Rising inclination of drug manufacturers to focus on core competencies such as R&D are observed to have a major impact on the yearly growth of contract research organizations
- Brazil held the largest share with respect to revenue generation in 2015
- Government’s current initiative to ensure GMP compliance among small and medium-sized pharma companies has contributed for the large share of Brazil
- Chile is expected to witness the fastest growth over the forecast period.
- Presence of companies offering bioanalytical, biomarker discovery, assay development, and cGMP analytical services can be attributed for the estimated growth
- Key players contributing in this market are Lonza; Charles River Laboratories S.A; Jubilant Life Sciences Limited; Boehringer Ingelheim GmbH; Pfizer, Inc. (Pfizer CenterOne); Albany Molecular Research, Inc; QuintilesIMS; and Pharmaceutical Product Development, LLC.
- These entities are involved in collaborations with therapeutic research organizations in order to enhance their industrial presence
See More
Reports of This Category:
About
Grand View Research:
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email:
sales@grandviewresearch.com
No comments:
Post a Comment